Insulet Competitors

PODD Stock  USD 243.15  8.09  3.22%   
Insulet competes with DexCom, STERIS Plc, Koninklijke Philips, Zimmer Biomet, and Biogen; as well as few others. The company conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Insulet competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Insulet to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Insulet Correlation with its peers.
For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.

Insulet vs Quest Diagnostics Correlation

Modest diversification

The correlation between Insulet and DGX is 0.21 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Insulet and DGX in the same portfolio, assuming nothing else is changed.

Moving against Insulet Stock

  0.53VMD Viemed HealthcarePairCorr
  0.51QIPT Quipt Home Medical Earnings Call This WeekPairCorr
  0.434DX 4DMEDICALPairCorr
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Insulet's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
240.87243.15245.43
Details
Intrinsic
Valuation
LowRealHigh
180.08182.36267.47
Details
Naive
Forecast
LowNextHigh
238.10240.38242.67
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
247.65287.86328.08
Details

Insulet Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Insulet and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Insulet and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Insulet does not affect the price movement of the other competitor.

High positive correlations

DGXLH
WSTZBH
WATSTE
WATBIIB
WSTWAT
WATZBH
  

High negative correlations

WSTLH
WSTDXCM
SNNWST
DGXBIIB
SNNWAT
LHBIIB

Risk-Adjusted Indicators

There is a big difference between Insulet Stock performing well and Insulet Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Insulet's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
DXCM  1.34  0.37  0.25  0.47  1.02 
 3.29 
 8.87 
STE  1.07  0.03  0.01  0.07  1.79 
 1.91 
 10.91 
PHG  1.17  0.00  0.00  0.03  1.74 
 2.43 
 8.74 
ZBH  1.09 (0.02)(0.02) 0.01  1.27 
 2.92 
 7.20 
BIIB  1.42  0.26  0.14  0.45  1.64 
 4.23 
 9.61 
LH  0.95  0.14  0.12  0.31  0.91 
 2.71 
 5.89 
WAT  1.14  0.08  0.07  0.11  0.99 
 3.35 
 8.85 
WST  1.50 (0.30) 0.00 (0.16) 0.00 
 2.64 
 12.18 
SNN  0.99  0.07  0.04  0.13  1.29 
 2.29 
 8.41 
DGX  1.06  0.11  0.07  0.66  1.04 
 2.68 
 6.29 

Insulet Competitive Analysis

The better you understand Insulet competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Insulet's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Insulet's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
PODD DXCM STE PHG ZBH BIIB LH WAT WST SNN
 3.22 
 243.15 
Insulet
 1.31 
 69.89 
DexCom
 7.74 
 243.81 
STERIS
 2.04 
 28.88 
Koninklijke
 0.73 
 88.73 
Zimmer
 0.05 
 185.36 
Biogen
 0.75 
 278.23 
Laboratory
 1.94 
 376.89 
Waters
 2.29 
 231.62 
West
 0.23 
 35.17 
Smith
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Five Year Return
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Last Dividend Paid
Shares Owned By Institutions
Market Capitalization
Price To Earnings To Growth
Price To Earning
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Insulet Competition Performance Charts

Five steps to successful analysis of Insulet Competition

Insulet's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Insulet in relation to its competition. Insulet's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Insulet in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Insulet's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Insulet, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Insulet position

In addition to having Insulet in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Macroaxis Picks Thematic Idea Now

Macroaxis Picks
Macroaxis Picks Theme
Daily selected watch list of stocks of large companies handpicked by Macroaxis Team based on their diversification potential. The Macroaxis Picks theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Picks Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Insulet is a strong investment it is important to analyze Insulet's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insulet's future performance. For an informed investment choice regarding Insulet Stock, refer to the following important reports:
Check out Insulet Correlation with its peers.
For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Will Health Care Equipment & Supplies sector continue expanding? Could Insulet diversify its offerings? Factors like these will boost the valuation of Insulet. Anticipated expansion of Insulet directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Insulet data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Insulet requires distinguishing between market price and book value, where the latter reflects Insulet's accounting equity. The concept of intrinsic value - what Insulet's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Insulet's price substantially above or below its fundamental value.
It's important to distinguish between Insulet's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Insulet should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Insulet's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.